Vanguard Group Inc Nexalin Technology, Inc. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 176,582 shares of NXL stock, worth $190,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176,582
Previous 159,878
10.45%
Holding current value
$190,708
Previous $158,000
2.53%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NXL
# of Institutions
22Shares Held
760KCall Options Held
0Put Options Held
0-
Myda Advisors LLC Inwood, NY150KShares$162,0000.04% of portfolio
-
Geode Capital Management, LLC Boston, MA122KShares$131,5650.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA62.5KShares$67,4970.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny55.7KShares$60,1560.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE55.5KShares$59,8980.81% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $7.86M